The shRNA-mediated loss of expression of the desmosomal protein plakophilin-2 leads to sodium current (I Na ) dysfunction. Whether pkp2 gene haploinsufficiency leads to I Na deficit in vivo remains undefined. Mutations in pkp2 are detected in arrhythmogenic right ventricular cardiomyopathy (ARVC). Ventricular fibrillation and sudden death often occur in the 'concealed phase' of the disease, prior to overt structural damage. The mechanisms responsible for these arrhythmias remain poorly understood. We sought to characterize the morphology, histology, and ultrastructural features of PKP2-heterozygous-null (PKP2-Hz) murine hearts and explore the relation between PKP2 abundance, I Na function, and cardiac electrical synchrony.
Introduction
The first descriptions of the intercalated disc defined three structures, all involved in cell -cell communication (desmosomes, adherens junctions, and gap junctions). It is now generally accepted that molecules not involved in forming a physical continuum between neighbouring cells also populate the intercalated disc. Key among them is Na v 1.5, the pore-forming subunit of the sodium channel most abundant in the heart. Recent studies have shown that Na v 1.5 functionally and physically interacts with other intercalated disc proteins, such as SAP-97, 1 Connexin43 (Cx43), 2, 3 and the desmosomal protein plakophilin-2 (PKP2). 3, 4 The latter studies further showed that the siRNA-mediated loss of PKP2 expression affects the amplitude and kinetics of the sodium current. These observations, however, were † Contributed equally.
limited to studies in isolated cells, where PKP2 expression was acutely disrupted in vitro. Whether PKP2 deficiency and, in particular, pkp2 haploinsufficiency leads to sodium current (I Na ) deficit in vivo, remains undefined. The importance of PKP2 in cardiac function is highlighted by the fact that mutations in the pkp2 gene are found in several cases of arrhythmogenic cardiomyopathy (AC; also known as 'arrhythmogenic right ventricular cardiomyopathy' or 'ARVC'). Of relevance, ventricular fibrillation and sudden death in patients with AC often occur in the 'concealed phase' of the disease, prior to overt structural damage (see ref. 5 for review). The mechanisms responsible for life-threatening arrhythmias in the concealed phase of AC remain unclear. We postulate that sodium channel function is disrupted by PKP2 haploinsufficiency. As such, we propose that sodium channel dysfunction may be a contributing factor to arrhythmogenesis in PKP2-deficient hearts. Germline knockout of PKP2 in mice leads to embryonic lethality. 6 However, heterozygous animals are viable and live through adulthood. The structural and functional consequences of PKP2 deficiency in the murine heart remain to be defined. In the present study, we conducted a general characterization of the anatomical, histological, and ultra-structural features of the hearts of mice heterozygous null for PKP2 (PKP2-Hz). Our studies revealed that the PKP2-Hz hearts showed ultrastructural, but not histological or gross anatomical differences, when compared with wild-type (WT) littermates. Yet, in myocytes from these structurally normal hearts, a sodium current deficit was observed. Previous studies have shown that the consequences of sodium current deficiency on cardiac electrophysiology can be unmasked by exposure to sodium channel blockers, such as flecainide. 7 -12 We therefore exposed isolated myocytes, Langendorffperfused hearts, and anaesthetized animals with the PKP2-Hz genotype, and their control littermates, to this drug. Our results show that in PKP2-Hz hearts, the extent of flecainide-induced usedependent I Na block, impaired ventricular conduction, and altered electrocardiographic parameters were larger than in controls. The pharmacological challenge also provoked ventricular arrhythmias and death in PKP2-Hz animals, but not in the WT controls. The possible implications of these findings to the pathophysiology of AC are discussed.
Methods
The methods for generation of the PKP2-Hz line and the characterization of homozygous-null animals have been reported before. 6 All experiments were conducted in PKP2-Hz and WT littermate mice, 3-6 months old, both genders. Mice were euthanized with an overdose of anaesthetic (isoflurane .20%) and confirmation of death by cervical dislocation. All procedures were carried out in accordance with New York University guidelines (IACUC Protocol 101101-02 to MD approved on 7 November 2011) for animal use and care and conformed to the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication 58-23, revised 1996). Detailed methods in Supplementary material online. Brief descriptions are as follows.
Myocyte isolation and cell electrophysiology
Adult mouse ventricular myocytes were obtained by enzymatic dissociation following standard procedures. All electrophysiological recordings were conducted in whole-cell configuration. Voltage clamp protocols were applied for determination of peak currentvoltage relation, steady-state activation, steady-state inactivation, and recovery from inactivation. 3 For assessing the effect of flecainide on peak sodium current amplitude, voltage clamp steps were applied repetitively every 300 ms. Control recordings (no drug added) were obtained for a total of 50 -60 s after patch break. Three minutes after drug addition, voltage clamp was switched back on and voltage clamp protocol reinitiated. The time-dependent peak sodium current amplitude decay curves were fit with bi-exponential functions.
Epicardial electrical mapping of Langendorff-perfused hearts
Hearts were placed on a Langendorff column and extracellular electrograms recorded using a 247-point terminal electrode (19 × 13 grid, 0.3 mm spacing) placed over both LV and RV. 13 -15 Recordings were made during stimulation from the centre of the grid. Measurements were repeated on the same hearts after 5 min of continuous perfusion of a Tyrode solution containing 0.53 mmol/L of flecainide.
Flecainide challenge and electrocardiographic recording in anesthetized mice
Mice were anaesthetized with isoflurane (5% for induction, then maintained at 1 -1.5% in 700 mL O 2 /minute via a nose cone), placed on a heating pad, and a single 'standard-lead' electrocardiogram (ECG) recorded through electrodes placed on limbs. After control recording, flecainide was applied in single bolus by intraperitoneal injection and ECG continuously monitored for 20 min (or arrhythmic death). 16 2.4 Protein identification, immunohistochemistry, histology, electron microscopy, and electron tomography
Experiments were carried out as in previous studies. 17 -19 Total murine heart lysate was prepared and equal amounts of protein (25 mg/lane) of each sample separated on SDS-polyacrylamide gels and transferred to nitrocellulose membranes. After first and second antibody incubation, immune reactivity was detected by ECL chemiluminescence. To detect protein localization by immunofluorescence, hearts were rapidly frozen in liquid nitrogen and stored at 2808C. Hearts were sectioned (thickness: 10 mm) in direction parallel to the long axis of the heart. Samples were exposed to polyclonal antibody against Na V 1.5 (1:100) 19 and mouse monoclonal antibody against N-Cadherin
(1:800, Sigma, Aldrich), or PKP2 (1:1000, Progen) and visualized by conventional epifluorescence microscopy. To evaluate extent of fibrosis, sections were fixed with 4% paraformaldehyde in PBS, stained with Picrosirius Red, and examined by light microscopy. For electron microscopy, mouse hearts were fixed in situ with 4% paraformaldehyde in 0.1 M PBS (pH 7.4); small pieces were cut, rapidly frozen with a high-pressure freezer, and stored under liquid nitrogen with 2% Osmium Tetroxide in acetone. Samples were slowly warmed by using an automated freeze substitution machine, infiltrated with acetone:Embed 812 resin 1:1, then incubated in twice pure Embed 812, and polymerized at 608C. Thin sections were collected on slotted copper grids. Samples were tilted between 270 and +708 at 18 intervals and electron micrographs recorded at 15 000 to 25 000 fold magnifications. A second tilt series of the same area was collected after manually rotating the specimen support by 908.
Results

General characterization of the animal model
PKP2-Hz mice and their WT littermates were used for the study. PKP2-Hz animals showed normal size and appearance. No difference in survival was observed when compared with WT littermates. Hearts from PKP2-Hz animals were also normal in appearance and weight (HW/BW ¼ 0.58 + 0.02; n ¼ 12 and 0.62 + 0.02; n ¼ 13 for WT and PKP2-Hz, respectively). Histological examination revealed no evidence of fibrotic infiltrates in PKP2-Hz compared with control ( Figure 1A ). Western blot analysis showed the expected decrease in PKP2 protein abundance, and no differences in abundance of other intercalated disc proteins (Cx43, N-Cadherin, plakoglobin, or Na V 1.5; Figure 1B ). Immunofluorescence studies showed an apparent decrease in intensity of PKP2 signals, which remained localized to the intercalated disc ( Figure 1C) . Similarly, no changes in localization of Na V 1.5, Cx43, plakoglobin, or N-Cadherin were observed at this level of resolution ( Figure 1D and Supplementary material online,
Figures S1 and S2). However, ultrastructural analysis of sections that ran parallel to fibre direction showed that desmosomes were sporadic or absent, the dimension of the intercellular space between structures was non-uniform and expanded in some areas, particularly at the crests of the area composita ( Figure 2 , left panels). These observations were consistent with those from other models of desmosomal deficiency. 20 Furthermore, tomographic electron microscopy (T-EM; Figure 2 and Supplementary material online, Video) revealed that the expanded intercellular space coincided with the presence of membrane invaginations in one side of the intercalated disc. Figure 2A -F shows selected planes of the same section, revealing that the invaginations extended several nanometres into the intracellular space; in some planes, the invaginations seemed to 'pinch off', leaving a healed membrane continuum facing the intercellular cleft. This observation was confirmed in three separate samples analysed by T-EM, and not found in controls. 18 
Sodium current properties in adult ventricular myocytes of PKP2-Hz mice
Previous studies have demonstrated that acute loss of PKP2 expression leads to decreased amplitude and shift in gating and kinetics of the sodium current (I Na ). 4 We therefore explored whether a similar effect would be observed in myocytes from PKP2-Hz hearts. As shown in Figure 3 , whole-cell patch clamp experiments revealed that average peak sodium current density in PKP2-Hz cells was significantly reduced when compared with control ( Figure 3A) . There was no difference in voltage dependence of activation ( Figure 3B ), but we observed a negative shift in steady-state inactivation ( Figure 3C) , and a slower recovery from inactivation ( Figure 3D ) in cells from PKP2-Hz animals when compared with control. Overall, our studies showed impairment of cardiac sodium current in cells from animals with reduced abundance of PKP2.
Flecainide-induced decrease in I Na is more pronounced in PKP2-Hz myocytes
Sodium channel blockers such as flecainide can help unveil an-otherwise masked or minimal-sodium current deficit. 7,8,10 -12,21 We explored whether the use dependence of flecainide block could be more pronounced in PKP2-Hz cells than in control. Figure 4A depicts the time course of average peak I Na density, relative to that at onset of recording, measured by 100 ms voltage clamp steps from 2120 to 230 mV applied, repetitively, every 300 ms. Control recordings (no drug) were obtained for 50 -60 s after patch break. Flecainide (1 mmol/L) was added to the superfusate at the time indicated by the upward arrow. No voltage clamp steps were applied for the first 3 min after addition of the drug (voltage clamp off; cell at resting membrane potential). After that period, membrane voltage was clamped again and the repetitive pulse protocol reinitiated. The peak current density elicited by the first pulse following quiescence reflected the magnitude of the 'tonic' (as opposed to 'use-dependent') blocking effect of the drug. Subsequent pulses elicited currents of progressively decreasing amplitude, reflecting the use dependence of the flecainide block. The reduction in I Na density was significantly larger in PKP2-Hz cells (red) than in control (black). Compiled data obtained from experiments testing three different flecainide concentrations are shown in Figure 4B and C. The bar graphs in Figure 4B show the extent of use-dependent block, whereas Figure 4C Table S1 for numerical parameters).
Flecainide-induced slow conduction velocity is more pronounced in PKP2-Hz hearts
Additional experiments explored the flecainide effect on electrophysiological parameters recorded by electrical epicardial activation mapping of Langendorff-perfused whole heart preparations. Figure 5A shows examples of activation maps from a littermate control (WT; left) and a PKP2-Hz mouse (right), in the absence or presence of 0.53 mmol/L of flecainide (drug concentrations of 1 mmol/L led to the loss of propagated activity in some preparations). I Na and arrhythmias in PKP2-heterozygous mice
The crowding of the isochrones reflects the fact that flecainide caused a decrease in longitudinal propagation velocity, which was most prominent in PKP2-Hz hearts. Cumulative data are shown in Supplementary material online, Table S2 . Graphs depicting the measurements of longitudinal conduction velocity for right and left ventricles are shown in Figure 5B and C, respectively. The data show that the flecainide-induced decrease was most prominent for RV propagation along the fibre direction (P , 0.02 vs. littermate controls), with the consequent decrease in anisotropic ratio for RV (Supplementary material online, Table S2 ). A similar tendency was observed for left ventricular propagation, although the difference was not statistically significant. Qualitatively, these results were reminiscent of those obtained in SCN5A haplo-insufficient hearts. 22 
Flecainide-induced electrocardiographic changes and ventricular arrhythmias in PKP2-Hz mice
Our results in isolated cells and whole heart preparations led us to explore genotype-dependent electrocardiographic differences. Singlelead, surface ECGs were recorded from anaesthetized animals. At baseline, PKP2-Hz animals presented significantly longer P wave duration; other ECG baseline parameters were similar to control (Supplementary material online, Table S3; Figure 6 ). A flecainide challenge (83 mmol/kg i.p.) caused a prolongation of the P and QRS durations, and of the PR and QTc intervals. In average, the flecainide effect was significantly more pronounced in PKP2-Hz animals than in control ( Figure 6A , left panel shows an example; Figure 6B and Supplementary material online Table S4 for cumulative data recorded at baseline, 5 ′ and 10 ′ ). A similar result was obtained when the relative increase in a given variable (as per cent of its magnitude at baseline) was analysed (Supplementary material online, Figure S3 and Table  S5 ). I Na and arrhythmias in PKP2-heterozygous mice
Discussion
We have shown that a decrease in PKP2 abundance associates with sodium channel dysfunction in mice. A significant difference in sodium current properties was observed in control ( Figure 3) ; the sodium current deficit was amplified by superfusion with flecainide ( Figure 4) . Flecainide also lead to genotype-dependent slowing of longitudinal conduction ( Figure 5 ), electrocardiographic changes ( Figure 6 ), and increased susceptibility to ventricular arrhythmias and death ( Figure 6 ). The electrophysiological phenotype was observed in the absence of overt structural disease (Figure 1) , although with an ultrastructural phenotype ( Figure 2) . Overall, our data support the notion that a genetically mediated decrease in PKP2 abundance can directly impair the function of the voltagegated sodium channel complex, and cardiac electrophysiological behaviour, even when structural integrity of the heart is not compromised. Together with our studies on the molecular interactions between PKP2 and components of the voltage-gated sodium channel complex, 3 and all differences between an animal model and a human disease being noted, our data suggest a potential mechanistic insight into the origin of arrhythmias that occur in patients with mutations in the pkp2 gene and no overt structural disease. ′ and 10 ′ after flecainide injection. A total of 11 WT and 12 PKP2-Hz animals were studied. Criteria for exclusion from data set: for P duration and PR interval, subject excluded from data set if ECG showed at least one of the following (number of excluded subjects from a given time point, in parentheses): (1) ventricular tachycardia, VT (4 PKP2-Hz at 10 ′ ), (2) second-degree AV block (5 WT, 3 PKP2-Hz at 10 ′ ), (3) atrial tachycardia, diagnosed for altered P polarity and shorter PR interval (one PKP2-Hz at 5 ′ and at 10 ′ ), or (4) P wave inversion, likely signalling a low atrial rhythm (two PKP2-Hz at baseline and at 5 ′ ). First two criteria also applied to QTc data set. For QRS duration, animals in VT were excluded; animals in second degree AV block were included, with parameters measured only from conducted sinus beats. n values indicated in each bar. *P , 0.05; **P ≤ 0.01. Additional data in Supplementary material online, Tables S3-S5 and Figure S3 .
Yet, sodium current may not be the only affected variable. Further studies will be necessary to determine whether junctional conductance, amplitude/kinetics of repolarizing currents, and/or extent of electrical heterogeneity are affected by the loss of PKP2 in a manner similar to what has been observed after the loss of other junctional molecules. 18,23 -25 Flecainide has primary effects as a use-dependent sodium channel blocker, and our results further found a genotype-dependent effect (Figure 4) . Both flecainide and PKP2 deficiency lead to slow recovery from I Na inactivation. 4, 26 We therefore speculate that the combination of both factors leads to a more extensive impairment of I Na during repetitive activation. Based on the results on isolated cells, we further speculate that the flecainide-induced changes in conduction velocity ( Figure 5 and Supplementary material online, Table S2 ) were primarily consequent to sodium current deficit. We also observed that flecainide had a more pronounced effect on conduction velocity in the right ventricle ( Figure 5B ). This is consistent with other studies showing that sodium current deficit leads to preferential impairment of propagation in the right ventricle. 27, 28 The mechanism for this effect is unknown, although it has been speculated that it relates to the fact that the RV-free wall is thinner, and it also shows sharp shifts in fibre orientation across the wall. The larger layer-to-layer rotational anisotropy may be associated with poor electrical coupling, slower conduction, and preferential sites for conduction block. 29, 30 Moreover, the right-vs.-left heterogeneity may have facilitated the initiation, and maintenance of ventricular arrhythmias in vivo ( Figure 6 ). The heterogeneous distribution of the sodium channel protein in the conduction system and across the ventricular wall may have also contributed to arrhythmogenesis. 27 Our results are also consistent with in silico studies demonstrating that PKP2-dependent changes in I Na can lead to initiation and sustainment of vortex activity. 31 It should be noted, however, that flecainide also has effects on other currents; 32 -35 moreover, disruption of the area composita (see our Figure 2 ) may affect potassium channels. 25 Whether PKP2 deficiency also affects other ion currents, and their response to flecainide treatment, remains to be determined. The experimental data, however, point to the sodium current deficit as a primary mechanism for the observed effects. A deficiency in PKP2 abundance has been associated with various cases of familial AC. 5 It has been suggested that arrhythmias in patients with AC are consequent to reentrant activity around anatomical obstacles. While such a mechanism is certainly possible, lifethreatening ventricular arrhythmias or sudden death often occur in the concealed phase of the disease, prior to overt structural damage. 5 The intimate mechanisms responsible for these arrhythmias are less clear. Decreased gap junction-mediated electrical coupling could be an adjuvant to arrhythmogenesis, although it is unlikely to be the only cause. 22, 36, 37 Obvious differences between animal models and clinical cases notwithstanding the data presented in this study support the notion that patients with haploinsufficiency in the pkp2 gene (mutation R79x, for example; see ref. 38, 39 ) may present a sodium current deficit. As in the case of the PKP2-Hz mice, this deficit may remain masked, but could be unveiled by an external trigger. In that regard, it is important to note that hearts from patients that have succumbed to ventricular fibrillation often reveal the presence of inflammatory infiltrates. Separate studies have revealed elevated levels of serum inflammatory mediators, and myocardial expression of IL-17 and TNF-alpha, in patients with AC. 40 Previous data suggest that cytokines can alter sodium current function. 41, 42 Future studies will address whether PKP2 is involved in modulating the response of I Na to cytokines, in a manner that would facilitate the loss of the cardiac rhythm in the setting of an inflammatory response in a PKP2-deficient heart. It is interesting to note that, as opposed to other animal models of desmosomal deficiency, PKP2-Hz mice do not develop a structural disease. The reason as to why decreased pkp2 gene dose and decreased PKP2 protein do not lead to the structural manifestations of AC in mice is unclear; yet, the observation is consistent with the limited penetrance of the structural disease, 5, 43 and supports the idea that epigenetic factors (e.g. an inflammatory response 40 ) perhaps not present in the 'sterile' environment of the laboratory animals, may be necessary to trigger fibrofatty infiltration. On the other hand, the model allows to study arrhythmogenic substrates related to PKP2 deficiency in the absence of structural involvement, a feature particularly helpful to understand the electrical phenotype of the desmosome-deficient heart in the concealed phase of the disease.
The present study focused on the phenotype of PKP2-Hz hearts. Whether other desmosomal proteins also interact with Na V 1.5, and whether these interactions occur in human heart, is currently under investigation. Recently, Gomes et al. 44 reported that desmoplakinheterozygous mice present average peak sodium current density similar to control; yet, careful analysis of their results suggests the possibility of technical limitations in their voltage clamp recordings, which could have masked small differences between the groups (see timing of peak current in the traces at the bottom of their Figure 1F , left-shift in Vm for peak current in the IV plot, and overall shape of IV curve; experiments carried out at [Na]o ¼ 25 mM; [Na]i ¼ 5 mM with patch electrodes of 3-4 MV); moreover, gating and kinetic properties were not thoroughly studied. On the other hand, patients with heterozygous mutations in desmoplakin and without overt structural disease showed significant regional conduction delays and heterogeneous Na V 1.5 distribution. 44 In summary, there is new evidence in support of the hypothesis, first proposed by our laboratory, 4 that I Na is affected by desmosomal mutations. Additional studies are necessary to better understand this interaction. Furthermore, characterizing the role of I Na in desmosome disease will be important as guidance on the indication or contraindication of sodium channel blockers in patients affected with AC. Finally, sodium channel blockers (including flecainide) are used as diagnostic tools in humans suspect of Brugada syndrome, a disease often associated with primary deficiency in sodium channel function. 9 Whether flecainide would aid in the evaluation of the arrhythmia risk in patients suspect of AC is an interesting area that deserves further investigation. 
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